30/06/25 -
04/07/25

Unlocking the future of medicine: Introduction to Preclinical Drug Discovery

At Pivot Park Life Science Campus, we believe in the power of lifelong learning to drive innovation. As part of our strategic goals, we’re excited to announce our annual “Introduction to Preclinical Drug Discovery” course, organised in collaboration with Radboud University, HAN University of Applied Sciences, and Crossfire Oncology. This course offers a comprehensive dive into the early stages of drug discovery, providing valuable insights into the latest technologies, challenges, and opportunities in pharmaceutical R&D.

A unique collaboration for Lifelong Learning

This course brings together experts from both academia and industry to provide participants with a solid understanding of modern drug discovery. Topics covered will include drug discovery principles, target identification and validation, medicinal chemistry, assay development, hit finding, and regulatory affairs. Participants will engage in a dynamic mix of lectures, seminars, group assignments, and site visits to companies at Pivot Park Life Science Campus.

This EFMC-certified course ensures high-quality education, helping participants gain practical knowledge they can apply in their professional careers.

For more information about the course and how to register, please visit the website.

door Idalia Dlugosz